Dow Up0.07% Nasdaq Up0.61%

Vertex Pharmaceuticals Incorporated (VRTX)

115.39 1.20(1.05%) Nov 26, 4:00PM EST
|After Hours : 115.40 Up 0.01 (0.01%) Nov 26, 4:39PM EST
Analyst OpinionGet Analyst Opinion for:
Recommendation Summary*
Mean Recommendation (this week):2.1
Mean Recommendation (last week):2.1

* (Strong Buy) 1.0 - 5.0 (Sell)

Price Target Summary
Mean Target:122.05
Median Target:126.50
High Target:175.00
Low Target:80.00
No. of Brokers:22

Data provided by Thomson/First Call

Upgrades & Downgrades History
DateResearch FirmActionFromTo
Nov 6, 2014CRT CapitalInitiated Buy
Jun 25, 2014H.C. WainwrightDowngradeBuyNeutral
Jan 6, 2014UBSUpgradeNeutralBuy
Oct 30, 2013Summer Street ResearchDowngradeBuyNeutral
Aug 22, 2013OppenheimerInitiated Outperform
Apr 19, 2013Canaccord GenuityUpgradeHoldBuy
Apr 10, 2013Chardan Capital MarketsInitiated Buy
Feb 7, 2013Robert W. BairdInitiated Outperform
Nov 28, 2012ArgusDowngradeBuyHold
Oct 4, 2012ArgusInitiated Buy

More Upgrades & Downgrades for VRTX

Data provided by - Take a free trial
Complete Live market analysis of the U.S. stock and bond markets, technology stocks, economic releases, earnings reports, and day trading highlights.

Recommendation Trends
Current MonthLast MonthTwo Months AgoThree Months Ago
Strong Buy7766

Data provided by Thomson/First Call

Currency in USD.